BE854265A - Medicament pour le traitement d'hyperliporoteinemies primaires et secondaires - Google Patents

Medicament pour le traitement d'hyperliporoteinemies primaires et secondaires

Info

Publication number
BE854265A
BE854265A BE177275A BE177275A BE854265A BE 854265 A BE854265 A BE 854265A BE 177275 A BE177275 A BE 177275A BE 177275 A BE177275 A BE 177275A BE 854265 A BE854265 A BE 854265A
Authority
BE
Belgium
Prior art keywords
hyperliporoteinemia
primary
treatment
medicinal product
medicinal
Prior art date
Application number
BE177275A
Other languages
English (en)
Inventor
G Metz
M Specker
Original Assignee
Merckle Kg Chem Pharm L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Kg Chem Pharm L filed Critical Merckle Kg Chem Pharm L
Publication of BE854265A publication Critical patent/BE854265A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE177275A 1976-05-17 1977-05-04 Medicament pour le traitement d'hyperliporoteinemies primaires et secondaires BE854265A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762621873 DE2621873C3 (de) 1976-05-17 1976-05-17 Arzneimittel zur Behandlung von Hypercholesterinämien

Publications (1)

Publication Number Publication Date
BE854265A true BE854265A (fr) 1977-09-01

Family

ID=5978183

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177275A BE854265A (fr) 1976-05-17 1977-05-04 Medicament pour le traitement d'hyperliporoteinemies primaires et secondaires

Country Status (3)

Country Link
BE (1) BE854265A (fr)
DE (1) DE2621873C3 (fr)
FR (1) FR2351658A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3411910A1 (de) * 1984-03-30 1985-10-10 Warner-Lambert Co., Morris Plains, N.J. Galenische zubereitung
US9173847B2 (en) 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
KR20060085686A (ko) 2003-10-10 2006-07-27 라이프사이클 파마 에이/에스 피브레이트를 포함하는 고형 제제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792421A (fr) 1971-12-11 1973-06-07 Merck Patent Gmbh Agent pour le traitement des hyperlipoproteinemies et son procede de preparation
DE2411768B2 (de) 1974-03-12 1976-07-01 Adenylchemie Gmbh, 1000 Berlin Arzneimittel mit lipoproteidsenkender wirkung

Also Published As

Publication number Publication date
DE2621873A1 (de) 1977-11-24
FR2351658A1 (fr) 1977-12-16
FR2351658B1 (fr) 1980-03-14
DE2621873B2 (de) 1980-08-28
DE2621873C3 (de) 1981-05-07

Similar Documents

Publication Publication Date Title
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE876157Q (fr) Medicament pour le traitement de l'acne
FI792863A (fi) Foerfarande foer igaongsaettning av aongpanna med tvaongscirkulation
BE889327A (fr) Preparations pharmaceutiques a base de peroxydes et d'erythromycines pour le traitement topique de l'acne
BE847095A (fr) Comprime pour la liberation controlee d'un medicament et sa preparation,
BE881208A (fr) Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci
BE873326A (fr) Medicament anti-cancereux et preventif des metastases cancereuses
FR2341315A1 (fr) Medicaments pour le traitement des neuropathies
FR2344291A1 (fr) Composition pour l'application topique d'un medicament
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE885290A (fr) Compositions pharmaceutiques pour le traitement des hyperlipidemies et des hyperlipoproteinemies
BE854265A (fr) Medicament pour le traitement d'hyperliporoteinemies primaires et secondaires
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
BE858507A (fr) Medicament antagoniste de l'action de la gastrine et des polypeptides apparentes
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE856006A (fr) Nouveaux medicaments pour le traitement des surcharges lipidiques et de la cellulite
FR2336945A1 (fr) Composition pour la sterilisation des femmes et des femelles d'animaux
BE860239A (fr) Preparation medicinale pour le traitement des neoformations malignes
FR2310767A1 (fr) Medicament pour le traitement de l'alopecia chronica diffusa
FR2520230B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
FR2334362A1 (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
FR2373561A1 (fr) Corticosteroides et medicaments qui en contiennent

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: LUDWIG MERCKLE K.G. CHEM. PHARM. FABRIK

Effective date: 19970504